[1] TAFT R J, PANG K C, MERCER T R, et al. Non-coding RNAs: regulators of disease[J]. The Journal of Pathology, 2010, 220(2): 126-139.

[2] PALAZZO A F, LEE E S. Non-coding RNA: what is functional and what is junk?[J]. Front Genet, 2015, 6: 2.

[3] CHEN Z, LI S, SUBRAMANIAM S, et al. Epigenetic regulation: a new frontier for biomedical engineers[J]. Annual Review of Biomedical Engineering, 2017, 19(1): 195-219.

[4] DENIZ E, ERMAN B. Long noncoding RNA (lincRNA), a new paradigm in gene expression control[J]. Funct Integr Genomics, 2017, 17(2/3): 135-143.

[5] KHANDELWAL A, BACOLLA A, VASQUEZ K M, et al. Long non-coding RNA: a new paradigm for lung cancer[J]. Molecular Carcinogenesis, 2015, 54(11): 1235-1251.

[6] WEI J W, HUANG K, YANG C, et al. Non-coding RNAs as regu-lators in epigenetics (review)[J]. Oncology Reports, 2017, 37(1): 3-9.

[7] LI T, MO X, FU L, et al. Molecular mechanisms of long non-coding RNAs on gastric cancer[J]. Oncotarget, 2016, 7(8): 8601-8612.

[8] BARTOSZEWSKI R, SIKORSKI A F. Editorial focus: entering into the non-coding RNA era[J]. Cellular & Molecular Biology Letters, 2018, 23: 45.

[9] YIN Y, YAN P, LU J, et al. Opposing roles for the lncRNA haunt and its genomic locus in regulating HOXA gene activation during embryonic stem cell differentiation[J]. Cell Stem Cell, 2015,16(5): 504-516.

[10] CESANA M, CACCHIARELLI D, LEGNINI I, et al. A long non-coding RNA controls muscle differentiation by functioning as a competing endogenous RNA[J]. Cell, 2011, 147(2): 358-369.

[11] STECK E, BOEUF S, GABLER J, et al. Regulation of H19 and its encoded microRNA-675 in osteoarthritis and under anabolic and catabolic in vitro conditions[J]. Journal of Molecular Medi-cine, 2012, 90(10): 1185-1195.

[12] YUAN J H, YANG F, WANG F, et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma[J]. Cancer Cell, 2014, 25(5): 666-681.

[13] HAMILTON M J, YOUNG M D, SAUER S, et al. The interplay of long non-coding RNAs and MYC in cancer[J]. Aims Biophys, 2015, 2(4): 794-809.

[14] RATHINASAMY B, VELMURUGAN B K. Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals[J]. Biomed Pharmacother, 2018, 102: 242-248.

[15] BALAS M M, JOHNSON A M. Exploring the mechanisms behind long noncoding RNAs and cancer[J]. Non Coding RNA Re-search, 2018, 3(3): 108-117.

[16] 杨思琦,姚颐,宋启斌.非小细胞肺癌中 LncRNA表达的研究现状[J].中国医药导报, 2019, 16(32): 38-41. YANG Siqi, YAO Yi, SONG Qibin, et al. Research status of Ln- cRNA expression in non-small cell lung cancer[J]. Guiding Jour-nal of Traditional Chinese Medicine and Pharmacy, 2019, 16(32): 38-41.

[17] YUAN C, NING Y, PAN Y. Emerging roles of HOTAIR in human cancer[J]. Journal of Cellular Biochemistry, 2020, 121(5/6): 3235-3247.

[18] JIANG C, YANG Y, YANG Y, et al. Long noncoding RNA (ln-cRNA) HOTAIR affects tumorigenesis and metastasis of non-small cell lung cancer by upregulating miR-613[J]. Oncology Research, 2018, 26(5): 725-734.

[19] CHEN R, CHEN B, LI D, et al. HOTAIR contributes to chemore-sistance by activating NF-κB signaling in small-cell lung cancer[J]. International Journal of Clinical and Experimental Pathology,2019, 12(8): 2997-3004.

[20] LIU M, ZHANG H, LI Y, et al. HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer[J]. Cancer Science, 2018, 109(9): 2717-2733.

[21] SUN Y, MA L. New insights into long non-coding RNA MALAT1 in cancer and metastasis[J]. Cancers, 2019, 11(2): 216.

[22] SHEN F, ZHENG H, ZHOU L, et al. Overexpression of MALAT1 contributes to cervical cancer progression by acting as a sponge of miR-429[J]. Journal of Cellular Physiology, 2019, 234(7): 11219-11226.

[23] 孙秀凤,周芬,吴婷.长链非编码 RNA MALAT1对NSCLS增殖、侵袭迁移及凋亡的影响[J].中国肿瘤外科杂志, 2020,12(2): 148-152, 157. SUN Xiufeng, ZHOU Fen, WU Ting. E.ects of long non-coding RNA MALAT1 on proliferation, invasion, migration and apopto-sis of NSCLS[J]. Chinese Journal of Surgical Oncology, 2020,12(2): 148-152, 157.

[24] TIANSHENG G, JUNMING H, XIAOYUN W, et al. lncRNA metastasis-associated lung adenocarcinoma transcript 1 promotes proliferation and invasion of non-small cell lung cancer cells via down-regulating miR-202 expression[J]. Cell Journal, 2020,22(3): 375-385.

[25] PARK JY, LEE J E, PARK J B, et al. Roles of long non-coding RNAs on tumorigenesis and glioma development[J]. Brain Tu-mor Research & Treatment, 2014, 2(1): 1-6.

[26] LU Y, TAN L, SHEN N, et al. Association of lncRNA H19 rs217727 polymorphism and cancer risk in the Chinese popula-tion: a meta-analysis[J]. Oncotarget, 2016, 7(37): 59580-59588.

[27] PARK IY, SOHN B H, CHOO J H, et al. Deregulation of DNA methyltransferases and loss of parental methylation at the insulin-like growth factor II (Igf2)/H19 loci in p53 knockout mice prior to tumor development[J]. Journal of Cellular Biochemistry, 2005,94(3): 585-596.

[28] YANG F, BI J, XUE X, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells[J]. FEBS Journal, 2012, 279(17): 3159-3165.

[29] ZHENG Z H, WU D M, FAN S H, et al. Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor pro-gression and development by targeting tumor suppressor p53 in non-small cell lung cancer[J]. Journal of Cellular Biochemistry, 2019, 120(11): 18724-18735.

[30] ZHAO Y, FENG C, LI Y, et al. LncRNA H19 promotes lung can-cer proliferation and metastasis by inhibiting miR-200a function[J]. Molecular and Cellular Biochemistry, 2019, 460(1/2): 1-8.

[31] YANG Y, WANG W, ZHANG L, et al. Association of single nu-cleotide polymorphism rs6983267 with the risk of prostate cancer[J]. Oncotarget, 2016, 7(18): 25528-25534.

[32] LING H, SPIZZO R, ATLASI Y, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chro-mosomal instability in colon cancer[J]. Genome Research, 2013,23(9): 1446-1461.

[33] QIU M, XU Y, YANG X, et al. CCAT2 is a lung adenocarcinoma-speci.c long non-coding RNA and promotes invasion of non-small cell lung cancer[J]. Tumour Biology, 2014, 35(6): 5375-5380.

[34] ZHAO C, QIAO C, ZONG L, et al. Long non-coding RNA-CCAT2 promotes the occurrence of non-small cell lung cancer by regulating the Wnt/β-catenin signaling pathway[J]. Oncology Letters, 2018, 16(4): 4600-4606.

[35] GHAFOURI-FARD S, OMRANI M D, TAHERI M. Long noncod-ing RNA PVT1: a highly dysregulated gene in malignancy[J]. Journal of Cellular Physiology, 2020, 235(2): 818-835.

[36] TSENG Y Y, BAGCHI A. The PVT1-MYC duet in cancer[J]. Molecular Cellular Oncology, 2015, 2(2): e974467.

[37] CUI M, YOU L, REN X, et al. Long non-coding RNA PVT1 and cancer[J]. Biochemical and Biophysical Research Communica-tions, 2016, 471(1): 10-14.

[38] CUI D,YU C H, LIU M, et al. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer[J]. Tumour Biology, 2016, 37(3): 4127-4134.

[39] MAO Z, XU B, HE L, et al. PVT1 promotes angiogenesis by regulating miR-29c/vascular endothelial growth factor (VEGF) signaling pathway in non-small-cell lung cancer (NSCLC)[J]. Medical Science Monitor, 2019, 25: 5418-5425.

[40] CHEN L, HAN X, HU Z, et al. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating au-tophagy and apoptosis[J]. Cancer Chemotherapy and Pharmacol-ogy, 2019, 83(5): 921-931.

[41] 李宝华,葛瑞胜,郭林顿,等. MEG3在肿瘤中作用的研究进展[J].医学综述, 2019, 25(12): 2354-2359. LI Baohua, GE Ruisheng, GUO Lindun, et al. Advances in research on effect of MEG3[J]. Medical Recapitulate, 2019,25(12): 2354-2359.

[42] ZHAO Y, ZHU Z, SHI S, et al. Long non-coding RNA MEG3 regulates migration and invasion of lung cancer stem cells via miR-650/SLC34A2 axis[J]. Biomed Pharmacother, 2019, 120: 109457.

[43] WU J L, MENG F M, LI H J. High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microR-NA-7-5p[J]. European Review for Medical Pharmacological Sci-ences, 2018, 22(18): 5938-5945.

[44] KRUER T L, DOUGHERTY S M, REYNOLDS L, et al. Expres-sion of the lncRNA maternally expressed gene 3 (MEG3) con-tributes to the control of lung cancer cell proliferation by the rb pathway[J]. Public Library of Science, 2016, 11(11): e0166363.

[45] MCCARTHY N. Epigenetics. Going places with BANCR[J]. Na-ture Reviews Cancer, 2012, 12(7): 451.

[46] SUN M, LIU X H,WANG K M, et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition[J]. Molecular Cancer, 2014,13: 68.

[47] YANG L, LIU G. lncRNA BANCR suppresses cell viability and invasion and promotes apoptosis in non-small-cell lung cancer cells in vitro and in vivo[J]. Cancer Management and Research, 2019, 11: 3565-3574.

[48] JIANG W, ZHANG D, XU B, et al. Long non-coding RNA BAN-CR promotes proliferation and migration of lung carcinoma via MAPK pathways[J]. Biomed Pharmacother, 2015, 69: 90-95.

[49] 胡以恒,张军.长非编码 RNA GAS5在恶性肿瘤中的表达及作用[J].国际肿瘤学杂志, 2016, 43(6): 445-447. HU Yiheng, ZHANG Jun. Expression and role of long non-coding RNA GAS5 in human carcinomas[J]. Journal of International Oncology, 2016, 43(6): 445-447.

[50] DONGL,LIG, LIY, et al. Upregulation of long noncoding RNA GAS5 inhibits lung cancer cell proliferation and metastasis via miR-205/PTEN axis[J]. Medical Science Monitor, 2019, 25: 2311-2319.

[51] XUE Y, NI T, JIANG Y, et al. Long noncoding RNA GAS5 in-hibits tumorigenesis and enhances radiosensitivity by suppressing miR-135b expression in non-small cell lung cancer[J]. Oncology Research, 2017, 25(8): 1305-1316.

[52] LI C, LUYL, SHAO C, et al. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis[J]. Journal of Cellular Physiology, 2019, 234(11): 20721-20727.

[53] SUN M, LIU X H, LU K H, et al. EZH2-mediated epigenetic sup-pression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by a.ecting the epithelial-mesen-chymal transition[J]. Cell Death & Disease, 2014, 5(6): e1298.

[54] YEY, GU J, LIU P, et al. Long non-coding RNA SPRY4-IT1 reverses cisplatin resistance by downregulating MPZL-1 via sup-pressing EMT in NSCLC[J]. Oncology Targets and Therapy, 2020, 13: 2783-2793.

[55] HE X, LIU Z, SU J, et al. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer[J]. Tumour Biology, 2016, 37(7): 9503-9510.

[56] XIAO X H, HE SY. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway[J]. European Review for Medical and Pharmacological Sciences, 2020, 24(6): 3130-3142.

[57] LI N, SHI K, KANG X, et al. Prognostic value of long non-coding RNA TUG1 in various tumors[J]. Oncotarget, 2017, 8(39): 65659-65667.

[58] NIU Y, MA F, HUANG W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2[J]. Molecular Cancer, 2017, 16(1): 5.

[59] ZHANG E B,YIN D D, SUN M, et al.P53-regulated long non-coding RNA TUG1 a.ects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression[J]. Cell Death & Disease, 2014, 5:e1243.

[60] 康小红,王颖,崔艳慧,等.肺岩宁方调控 MALAT1抑制 A549肺癌细胞侵袭的机制研究[J].上海中医药杂志, 2019, 53(3): 77-82. KANG Xiaohong, WANG Ying, CUI Yanhui, et al. Mechanism study on Feiyanning recipe inhibiting invasion of A549 lung can-cer cells by regulating MALAT1[J]. Shanghai Journal of Tradi-tional Chinese Medicine, 2019, 53(3):77-82.

[61] 蒋梅,张晶,张恩欣,等.益气除痰方下调 MALAT-1表达对肺癌细胞发生上皮间质转化的影响[J].中华中医药学刊,2019, 37(11): 2592-2596. JIANG Mei, ZHANG Jing, ZHANG Enxin, et al. Effect of Yiqi Chutan formula on inhibiting of epithelial-mesenchymal transi-tion in lung cancer cells by down-regulating MALAT-1[J]. Chinese Archives of Traditional Chinese Medicine, 2019, 37(11): 2592-2596.

[62] 刘斌斌,韩志远,蒋义国.白藜芦醇抑制人肺癌 A549细胞生长过程中长链非编码 RNA BC043009的作用[J].现代预防医学, 2013, 40(7): 1313-1315, 1322. LIU Binbin, HAN Zhiyuan, JIANG Yiguo. The role of long non-coding RNA BC043009 on inhibition the growth of A549 cells induced by resveratrol[J]. Modern Preventive Medicine, 2013,40(7): 1313-1315, 1322.

[63] YANG Q Y, XU E, DAI J, et al. A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer[J]. Fundamental and Ap-plied Toxicology Toxicol Applied Pharmacol, 2015, 285(2): 79-88.

[64] JIANG R, HU C, LI Q, et al. Sodium new houttuyfonate sup-presses metastasis in NSCLC cells through the Linc00668/miR-147a/slug axis[J]. Journal of Experimental & Clinical Cancer Re-search, 2019, 38(1): 155.

[65] XU J, SU C, ZHAO F, et al. Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation[J]. Biochemical and Biophysical Research Communications, 2018, 504(1): 123-128.

[66] HERBST R S, MORGENSZTEM D, BOSHOFF C. The biology and management of non-small cell lung cancer[J]. Nature, 2018,553(7689): 446-454.